The main antigens used for peptide-based vaccines in HCC include epitopes from oncofetal antigen alphafetoprotein (AFP) [77,78] and glypican 3 (GPC-3) [79], and the human telomerase reverse transcriptase (hTERT) peptide GV1001 [80]. Here, GPC3 is linked to hepatocellular carcinoma.